David Shaw’s Soleno Therapeutics SLNO Stock Holding History

David Shaw’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-36,900	Closed	-$2.64M	–	4687
2025 Q1	$2.64M	Buy	+36,900	New	+$1.8M	﹤0.01%	2405

David Shaw's SLNO Position: Q2 2026 in Review

David Shaw sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 30,247 shares — an estimated $1.01M sold.

David Shaw first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $9.61M in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

David Shaw reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
David Shaw sold 30,247 Soleno Therapeutics shares in Q2 2026, an estimated $1.01M.
David Shaw first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
David Shaw's Soleno Therapeutics position peaked at $9.61M in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.